Clinical Trial Update: Study of Tazemetostat in Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of tazemetostat in T-cell lymphoma has been terminated; sponsor University of Alabama at Birmingham is conducting this trial (NCT05983965) in lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• TAZVERIK (TAZEMETOSTAT)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: T-cell Lymphoma | Phase 1 | Status: TERMINATED